Evidence map›Paper›PMID 30669336›Full record

ArticleInternational journal of molecular sciences2019

Peach Kernel Oil Downregulates Expression of Tissue Factor and Reduces Atherosclerosis in ApoE knockout Mice.

Erwei Hao, Guofeng Pang, Zhengcai Du, Yu-Heng Lai, Jung-Ren Chen, Jinling Xie, Kai Zhou, Xiaotao Hou, Chung-Der Hsiao, Jiagang Deng

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. From Biorefinery to Food Product Design: Peach (Food and bioprocess technology · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Mechanism of Yifei Decoction Combined with MitoQ on Inhibition of TGFEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Erwei HaoGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China. ewhao@163.com.
Guofeng PangGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China. pangguof@126.com.
Zhengcai DuGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China. duzhengcai8@163.com.
Yu-Heng LaiDepartment of Chemistry, Chinese Culture University, Taipei 11114, Taiwan. lyh21@ulive.pccu.edu.tw.
Jung-Ren ChenDepartment of Biological Science & Technology College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan. jrchen@isu.edu.tw.
Jinling XieGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China. 13257716536@163.com.
Kai ZhouGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China. zhoukai46@126.com.
Xiaotao HouGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China. xthou@126.com.
Chung-Der HsiaoDepartment of Bioscience Technology, Chung Yuan Christian University, Chung-Li 32023, Taiwan. cdhsiao@cycu.edu.tw.ORCID 0000-0002-6398-8672
Jiagang DengGuangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China. denggjg53@126.com.
Guangxi University · CNChinese Culture University · TWChung Yuan Christian University · TWI-Shou University · TW

Funding

Guangxi Natural Science Foundation 2013GXNSFBA019145Guangxi Science and Technology Plan Project AD17129010, 17-259-20, AD17195025
6 · The paper itself

Abstract

Atherosclerosis is the pathological process in arteries due to the plaque formation that is responsible for several diseases like heart disease, stroke and peripheral arterial disease. In this study, we performed in vitro and in vivo assays to evaluate the potential anti-atherosclerosis activity of peach kernel oil. For the in vitro assay, we incubated human umbilical vein endothelial cells (HUVEC) with tumor necrosis factor-α (TNF-α) to induce tissue factors (TF, an essential mediator of hemostasis and trigger of thrombosis) elevation. We found that TNF-α-induced TF elevation was suppressed by peach kernel oil in a dose-dependent manner at both mRNA and protein levels. Peach kernel oil can significantly improve HUVEC viability, protect the endothelial cells, which achieved the goal of prevention of thrombotic diseases. For the in vivo assay, we investigated the effect and mechanism of peach kernel oil on preventing atherosclerotic lesion formation in ApoE knockout mice. Results show that peach kernel oil could reduce total cholesterol, triglyceride, low-density lipoprotein cholesterol levels, elevate the high-density lipoprotein cholesterol level in serum, and reduce the area of the aortic atherosclerotic lesions in high-fat diet fed ApoE knockout mice. Moreover, peach kernel oil treatment can significantly down regulate the expression of TF protein to inhibit the formation of atherosclerotic plaque. In conclusion, peach kernel oil may be a potential health food to prevent atherosclerosis in cardiovascular diseases.

Indexed as

AnimalsAortaAtherosclerosisCell LineCell SurvivalDisease Models, AnimalFatty AcidsGene Expression RegulationHumansHuman Umbilical Vein Endothelial CellsMiceMice, Knockout, ApoEModels, BiologicalPhytochemicalsPlant OilsPlaque, AtheroscleroticFatty AcidsPhytochemicalsPlant OilsRNA, MessengerThromboplastinTumor Necrosis Factor-alphaatherosclerosishuman umbilical vein endothelial cellspeach kernel oiltissue factortumor necrosis factor-α

Identifiers

PMID30669336
PMCPMC6359210
OpenAlexW2910280713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.